-
The scale exceeds 600 billion, and innovative drug achievements are frequent Shanghai's pharmaceutical industry has shown strong resilience and vitality
Time of Update: 2022-12-04
It is reported that since the beginning of this year, Shanghai has started 32 new major projects with an investment of nearly 8 billion yuan, including the second phase of Bibo Bio's large-scale CDMO integrated platform, the construction project of Berger Medical Industrial Base, the intuitive Fosun headquarters and industrialization base, and the R&D capability and production quality improvement and transformation project of Hehuang Pharmaceutical.
-
Professor Li Yonghong: Mid-year inventory - 2022 prostate cancer memorabilia
Time of Update: 2022-10-14
In addition to triple therapy, other new treatment options for mHSPC are also being carried out simultaneously, ASCO Conference Abstract 5005 shows that compared with bicalutamide combined with ADT, rveruride combined with ADT significantly improves the rPFS of high tumor load mHSPC, which has received widespread attention from domestic urological oncologists, Professor Li Yonghong said that this drug may become one of the most important treatment options for Chinese patients in the future.
-
To avoid the pit of kidney stones, you may wish to do a "private custom" metabolic assessment
Time of Update: 2022-10-13
Can't people with kidney stones eat spinach?Spinach is high in oxalic acid, and eating too much spinach may cause an increase in urinary oxalic acid, but due to the different mechanisms of kidney stone formation of different components, it is only necessary to limit the dietary intake of oxalic acid only if calcium oxalate stones are considered by clinical history or stone analysis or if there is a clear hyperoxaluria.
-
Henan University Shi Bingyang's team developed a new type of nanocapsules, breaking the blood-brain barrier and efficiently editing brain tumor cells
Time of Update: 2022-06-06
Zheng Meng from the Henan University-Macquarie University Biomedical Joint Innovation Center from the School of Life Sciences, Henan University, as co-corresponding authors, published a paper entitled: Blood-brain barrier–penetrating in Science Advances, a sub-journal of Science Research paper on single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy .
-
The most difficult collection in history: dental implants stuck in the "mouth
Time of Update: 2022-04-29
In February 2022, the relevant person in charge of the National Medical Insurance Bureau said: "In the first half of this year, we will strive to launch a coalition reform of the local centralized procurement of dental implants .
-
The State Food and Drug Administration issued 14 guidelines for registration review including fluorescence immunochromatography analyzers
Time of Update: 2022-01-27
48 of the State Administration for Market Regulation), the State Drug Administration organized and formulated 14 guiding principles for registration and review of fluorescence immunochromatography analyzers (see attachments).
Guidelines for the registration and review of fluorescence immunochromatography analyzers 2.
-
Five-year outlook: After the "three medical" data linkage, the national market will be unified and changed
Time of Update: 2022-01-09
, and unblock data sharing channels between departments, regions, and industries "Three-medicine linkage" big data application imagination and preparations for pharmaceutical companies Through the efforts of the "14th Five-Year Plan", the data of medical care, medical insurance and medicine has gradually improved standards and information processing specifications from decentralization and fragmentation, unified data structure and improvement of data transmission and storage.
-
In 2023, my country’s cardiovascular and cerebrovascular disease drug market will exceed 280 billion yuan
Time of Update: 2022-01-02
In the "Healthy China Action (2019-2030)", specific instructions were made on the prevention and treatment of cardiovascular and cerebrovascular diseases, and it was clearly necessary to promote the "three highs" co-management to carry out overweight and obesity, increased blood pressure and blood sugar, and dyslipidemia and other high-risk groups.
-
Gan Lai announced that the farnesol X receptor agonist ASC42 for the treatment of primary biliary cholangitis Phase II and III clinical trial protocol was approved by the China National Food and Drug
Time of Update: 2021-12-07
Based on the Phase II and Phase III clinical trial protocol of ASC42 for the treatment of PBC approved by the National Food and Drug Administration of China, Gan Lai will conduct phase II clinical trials in 100 patients with insufficient or intolerance to ursodeoxycholic acid (UDCA).
-
Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 rankings have changed, Yangzijiang and others will be the first to imitate
Time of Update: 2021-12-05
The 30 billion market makes waves againSales of Fondaparinux Sodium Injection in Public Medical Institutions in China (Unit: 100 million yuan)Source: Mi Nei. com, China's public medical institutions terminal competition patternA few days ago, Yangtze River Jiangsu Zilong Pharmaceutical's Fondaparinux Sodium Injection was approved as a supplementary application, and it is the fourth company that has reviewed the product .
-
In the first half of the year, the performance of the Chinese medicine sector was excellent, and the second half of the year continued to be optimistic
Time of Update: 2021-10-09
The industry believes that the outstanding performance of the Chinese medicine sector in the first half of the year was mainly due to the fact that frequent favorable policies + consumption attributes + valuation advantages constitute industry opportunities .
-
2020 China's health new power enterprise collection activities released Ted Pharmaceuticals won the title of new force enterprise in the chemical agent industry
Time of Update: 2021-01-03
2020 China's new health force enterprise collection activities awards are divided into ten, including "new power enterprises in the Chinese medicine industry", "new forces enterprises in the chemical
-
Expert: The incidence of inflammatory bowel disease has been rising in recent years Clinical diagnosis and treatment should pay attention to the quality of life of patients
Time of Update: 2020-06-23
BEIJING, May 19 (Xinhua Li Yanan) A study on inflammatory bowel disease (IBD) data shows that nearly 50% of patients said the disease seriously affects their ability to work and activity Experts poi
-
In 2019, online pharmacy sales exceed 100 billion, will usher in a period of rapid development
Time of Update: 2020-05-30
Pharmaceutical Network Market Analysis May 24, a website published the "three terminals of the six major market online pharmacy drug analysis." According to the data, sales of brick-and-mortar phar
-
U.S. Aviation Medical True Level Exposure: The Real Life-and-Death Speed
Time of Update: 2020-05-13
the 12th issue of the Air Force Journal published Amy McCullough's article: Life Flight The article introduces the entire process by which the medical team of the 433rd Air Medical Evacuation Squa
